Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
Marinus Pharmaceuticals (MRNS) - Net assets
Net assets on the balance sheet as of December 2023 : $16.76 M
According to Marinus Pharmaceuticals's latest financial reports the company has $16.76 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Marinus Pharmaceuticals - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $16.76 M | -85.55% |
| 2022-12-31 | $0.11 B | 116.88% |
| 2021-12-31 | $53.48 M | -61.02% |
| 2020-12-31 | $0.13 B | 56.32% |
| 2019-12-31 | $87.76 M | 28.46% |
| 2018-12-31 | $68.32 M | 17.79% |
| 2017-12-31 | $58 M | 170.07% |
| 2016-12-31 | $21.47 M | -54.22% |
| 2015-12-31 | $46.92 M | 14.01% |
| 2014-12-31 | $41.15 M | 335.12% |
| 2013-12-31 | $9.45 M | 126.15% |
| 2012-12-31 | $4.18 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $0.92 B | 5,396.67% | 🇺🇸 USA |
 Endo International
ENDPQ | -$6.6 B | -39,453.18% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | $14.1 M | -15.87% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $0.25 B | 1,403.37% | 🇺🇸 USA |